Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting

European Heart Journal

Volumn 36, Issue 2, 2015, Pages 94-99

  Cassese, Salvatore ^a   Byrne, Robert A ^a   Schulz, Stephanie ^a   Hoppman, Petra ^a   Kreutzer, Johanna ^a   Feuchtenberger, Antonia ^a   Ibrahim, Tareq ^a   Ott, Ilka ^a   Fusaro, Massimiliano ^a   Schunkert, Heribert ^a   Laugwitz, Karl Ludwig ^a   Kastrati, Adnan ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Angiography; Coronary artery disease; Mortality; Restenosis

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY STENT; CORONARY STENTING; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SMOKING HABIT; ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; DRUG ELUTING STENT; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PROGNOSIS; RADIOGRAPHY; RESTENOSIS; STENT;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROGNOSIS; STENTS;

EID: 84925340732     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu383     Document Type: Article

References (25)

1. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL, Kastrati A. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014;100:153-159
2. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol 2014;63:2659-2673
3. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005;111:3435-3442
4. Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 2008;51:23-32
5. Byrne RA, Eberle S, Kastrati A, Dibra A, Ndrepepa G, Iijima R, Mehilli J, Schomig A. Distribution of angiographic measures of restenosis after drug-eluting stent implantation. Heart 2009;95:1572-1578
6. Brener SJ, Prasad AJ, Khan Z, Sacchi TJ. The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials. Atherosclerosis 2011;214: 158-162
7. Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of 'oculostenotic' reintervention in patients with intermediate lesions. JACC Cardiovasc Interv 2010;3:403-411
8. Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Lansky AJ, Mehran R. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 2010;56:1597-1604
9. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;59: 1995-2027
10. Weintraub WS, Ghazzal ZM, Douglas JS Jr, Morris DC, King SB III. Usefulness of the substitution of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris. Am J Cardiol 1998;81:382-386
11. Rupprecht HJ, Espinola-Klein C, Erbel R, Nafe B, Brennecke R, Dietz U, Meyer J. Impact of routine angiographic follow-up after angioplasty. Am Heart J 1998;136 (4 Pt 1):613-619
12. Schuhlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schomig A. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004;147:317-322
13. Heiberger RM. HH: Statistical Analysis and Data Display: Heiberger and Holland, 2013. http://CRAN.R-project.org/package=HH.
14. Harrell FE Jr, Dupont C. Harrell Miscellaneous, 2012. http://CRAN.R-project. org/package=Hmisc
15. Gould KL, Lipscomb K, HamiltonGW. Physiologic basis for assessing critical coronary stenosis. Instantaneous Flow Response and Regional Distribution During Coronary Hyperemia as Measures of Coronary Flow Reserve.Am J Cardiol 1974;33:87-94
16. Kuntz RE, Baim DS. Defining coronary restenosis. Newer Clinical and Angiographic Paradigms. Circulation 1993;88:1310-1323
17. Eeckhout E, Serruys PW, Wijns W, Vahanian A, Van Sambeek M. In: Percutaneous Interventional Cardiovascular Medicine: the PCR - EAPCI Textbook. Europa Ed.; 2012 p. 785-826
18. Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, Faxon DP, Feit F. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 2013;347:f6625
19. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007;297: 1992-2000
20. Ruygrok PN, Melkert R, Morel MA, Ormiston JA, Bar FW, Fernandez-Aviles F, Suryapranata H, Dawkins KD, Hanet C, Serruys PW. Does angiography six months after coronary intervention influence management and outcome?. Benestent II Investigators. J Am Coll Cardiol 1999;34:1507-1511
21. Lansky AJ, Brar SS, Yaqub M, Sood P, Applegate RJ, Lazar D, Jankovic I, Hermiller JB, Koo K, Sudhir K, Stone GW. Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. Am J Cardiol 2012;110:21-29
22. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ, Investigators T-I. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 2006; 48:32-36
23. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol 2012;59: 2051-2057
24. Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 2005;112:2833-2839
25. Mancini GB, Hartigan PM, Shaw LJ, Berman DS, Hayes SW, Bates ER, Maron DJ, Teo K, Sedlis SP, Chaitman BR, Weintraub WS, Spertus JA, Kostuk WJ, Dada M, Booth DC, Boden WE. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv 2014;7:195-201